Twitter Linkedin-in

Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics

28 April 2021 | GMT (UTC+0)
Part of the Biologics Series
Biologics Europe: Online
Virtual Symposium: Oligonucleotides
Biologics UK: In-Person
Biotherapeutics US: Online
Virtual Symposium:
Oligonucleotides: Chemistry & Therapeutics28 April 2021 | BST (UTC+1)
An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics
Download Agenda
Register
The programme brings together world leaders from international pharmaceutical organisations and leading academic institutions to discuss the latest in Oligonucleotides
Download Agenda
Full details on the symposium, including the presentations, topic areas and confirmed speakers can be found in the conference brochure
Download Brochure
Book Online
Registration for Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics is now open. Please click the button below to register your interest.
Register
LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts working in proteins, bispecifics, peptides and oligonucleotides

Visit Group

Virtual Symposium:
CTCs & Liquid Biopsies
is sponsored by

Programme

The Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics includes...

Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within Oligonucleotides

  • Hear from and meet with the leading figures in oligonucleotide chemistry, analytical development, and therapeutics; offering in-depth presentations and new ideas you can use to advance your research
  • Gain insights into the latest innovation in oligo analytical methods, purification technology development, delivery methods of oligos and advanced synthesis techniques
  • Interact with speakers during the live Q&As, taking place at the end of each presentation and participate in our interactive panel discussions focusing on key challenges & market opportunities
  • Explore case studies pertaining to how oligonucleotides are used in therapeutics through looking at specific areas such as advancements in oligo therapeutics for oncology, genetic disorders, infectious diseases as well as miRNA therapeutics

Agenda at a Glance

Morning Session: Synthesis, Chemistry, Process & Analytical Development

  • Advanced synthesis technologies
  • Oligo delivery methods
    • Oral Delivery
    • Lipid nanoparticles delivery
    • Injected/subcutaneous delivery
  • Purification technology development:
    • Freeze-drying
    • Chromatography
  • Impurity analysis

Afternoon Session: Oligo & miRNA Therapeutics

  • Oligo therapeutics:
    • Oncology
    • Genetic disorders
    • Cardiovascular diseases
    • Rare diseases
    • Infectious diseases
  • miRNA therapeutics

Confirmed Speakers

The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future

chandra-vargeese

Chandra Vargeese

Wave Life Sciences

Punit_Seth

Punit Seth

Ionis Pharmaceuticals

steve hood

Steve Hood

GlaxoSmithKline

charles sinclair

Charles Sinclair

Bristol-Myers Squibb

michael keller

Michael Keller

F.Hoffman-La Roche Ltd
Andrew Livingstone

Andrew Livingston

Queen Mary University of London

Event Features​

Networking and knowledge Sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual, remote experiences. 

Virtual Presentations

Benefit from the insight of our expert speakers via live and pre-recorded presentations

Live Q&As

Interact with fellow attendees and speakers during the live Q&As at the end of each presentation

Digital Networking Opportunities

Connect directly with other registrants of event around the world
Immuno Webinar: How CD8 Imaging Is Useful To Pharma Regarding Drug Research & Clinical Decision Making
Biologics 2019 Post-Event Report
Statistics, feedback, photos and more from last year's event.
The Design And Development Of A Connected Inhalation System To Help With Monitoring
Complimentary Webinar
Webinar on 'Nanofitin-Antibody fusion as a novel multispecific platform. Hosted by Mathieu Cinier, Scientific Director, Affilogic.
Bioconjugation and New Target Discovery
Q&A with Novo Nordisk's Scientific Director, Thomas Hoeg-Jensen
Immuno Webinar: How CD8 Imaging Is Useful To Pharma Regarding Drug Research & Clinical Decision Making
Complimentary Webinar
From Andy Parker, Senior Vice President & Chief Scientific Officer, Zealand Pharma: From Peptide Discovery to Phase 3 – A Zealand Perspective
Q&A Session with Antonin De Fougerolles
Chief Executive Officer of Evox Therapeutics, Antonin De Fougerolles: The Role of Bispecific Antibodies within the Healthcare Industry
Ivan Plavec, Chief Business Officer at ImaginAB
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.